FIELD: medicine.
SUBSTANCE: group of inventions refers to balloon catheters either with a corrugated stent or without it, the surface of which is coated with at least one antirestenosis therapeutic agent and at least one transport promoting molecular dispersing agent, as well as to a method for making these medical devices.
EFFECT: balloon catheter coating effectively reduces the premature release of the agents from the surface of the balloon catheters and provides the agent delivery from the balloon surface to a vascular wall in the highest effective form.
14 cl, 2 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PRODUCT WITH PARTICLE-FREE COATING RELEASING ACTIVE SUBSTANCE | 2011 |
|
RU2578422C2 |
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2458710C2 |
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2447901C2 |
| BIODEGRADABLE DEVICE FOR VESSEL LUMEN MAINTENANCE | 2008 |
|
RU2452517C2 |
| STENT | 2007 |
|
RU2432183C9 |
| DISSOLVING STENTS CONTAINING MAGNESIUM ALLOYS | 2012 |
|
RU2642254C2 |
| CATHETER CYLINDER | 2011 |
|
RU2633723C2 |
| COATING COMPOSITION AND MEDICAL DEVICE | 2013 |
|
RU2605291C2 |
| DRUG COATING LAYER | 2014 |
|
RU2648469C2 |
| ENDOPROSTHESIS, COATED WITH ACTIVE COMPOUND | 2012 |
|
RU2592367C2 |
